from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1232c/-

LFCtreatmentdescriptionclass of inhibitor

-1.635

Amikacinug/mL Amikacintranslation

-1.030

Cap5-10ug/mL Capreomycintranslation

-1.622

Rox10-50 ug/mL Roxithromycintranslation

-0.351

SM2-5 ug/mL Streptomycintranslation

-1.685

Tet5-10 ug/mL Tetracyclinetranslation

0.336

Rif0.2-5ug/mL Rifampicintranscription

-1.635

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.142

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.382

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.454

CPZ10-50 ug/mL Chlorpromazinerespiration

0.338

Clofazimine10-13 ug/mL Clofaziminerespiration

0.265

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.943

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.037

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.249

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.703

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.227

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.915

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.319

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.129

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.231

KCN5-20 ug/mL Potassium cyaniderespiration

1.038

NaN30.2-2 mM Sodium aziderespiration

2.015

Nigericin50 uM Nigericinrespiration

0.385

TRC10-150 ug/mL Triclosanrespiration

-0.166

TRZ10-25 ug/mL Thioridazinerespiration

-2.585

Valinomycin0.5-10 uM Valinomycinrespiration

0.932

ZnSO42 mM ZnSO4respiration

-0.370

menadione6-10 ug/mL Menadionerespiration

-0.403

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.409

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.723

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.732

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.303

NRP_1Non-replicating persistence stage 1dosRassociated

0.360

Amp0.2mg/mL AmpicillincellWall

0.068

Cephalexin20-100 ug/mL CephalexincellWall

0.299

Cerulenin0.32-5 ug/mL CerulenincellWall

0.502

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.357

EMB10-20 ug/mL EthambutolcellWall

-0.316

Eta12-40 ug/mL EthionamidecellWall

-0.920

INH0.2-0.4 ug/mL IsoniazidcellWall

0.260

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.828

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.935

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.403

BZA0.12 mg/mL BenzamidearomaticAmides

-0.115

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.236

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.584

H2O24 mM hydrogen peroxideDNAdamaging

-0.536

Levo10 ug/mL LevofloxacinDNAdamaging

0.560

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.923

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.075

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.200

UVUV-irradiationDNAdamaging

-1.251

ARP41-4 ug/mL Antitubercular compound ARP4?

0.600

Antimycin12.5-50 ug/mL Antimycin A?

0.961

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.403

PA_110-50 ug/mL Antitubercular compound PA-1?

0.466

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.254

PA8240.2-2 ug/mL PA-824?

-0.406

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.171

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.123

Verapamil50 uM Verapamil?

0.801

mercaptoethanol2 mM 2-Mercaptoethanol?

1.004

methoxatin10-20 ug/mL Methoxatin?